Effect of the Number of Inseminated Spermatozoa on Subsequent Human Embryonic Development in Vitro

This study has been completed.
Information provided by:
University Hospital, Gasthuisberg
ClinicalTrials.gov Identifier:
First received: January 4, 2008
Last updated: July 2, 2008
Last verified: January 2008

In order to reach fertilization in the context of IVF, the presence of high concentrations of spermatozoa is associated with a higher degree of sperm metabolism and a higher concentration of sperm degradation products, which may adversely affect not only sperm and oocyte viability and the fertilization rate. The effect of a high concentration of sperm used for oocyte insemination appears also to be negative on embryo development (Dumoulin et al 1992*). If that is true, lowering the sperm concentration for oocyte insemination might improve embryo quality and result in a higher implantation rate per embryo. Therefore, we tested the hypothesis that the percentage of 8 cell-embryos on day 3 after IVF is significantly higher (40%) after insemination with a low sperm concentration (150 000/ml spermatozoa) than after insemination with a higher sperm concentration (30%; group 600 000/ml spermatozoa).

Condition Intervention
Spermatozoa and Embryos
Procedure: Insemination

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: Effect of the Number of Inseminated Spermatozoa on Subsequent Human Embryonic Development in Vitro

Further study details as provided by University Hospital, Gasthuisberg:

Primary Outcome Measures:
  • embryo quality [ Time Frame: 36 hours ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • implantation rate [ Time Frame: 9 months ] [ Designated as safety issue: Yes ]

Enrollment: 82
Study Start Date: August 2006
Arms Assigned Interventions
Experimental: 1
Insemination of the oocytes with a lower concentration of spermatozoa.
Procedure: Insemination
Insemination with a lower concentration of spermatozoa: 150 000 spermatozoa/ml
No Intervention: 2
Insemination with a normal concentration of spermatozoa.

  Show Detailed Description


Ages Eligible for Study:   18 Years to 43 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • All patients with at laest 4 oocytes
  • A sperm sample with a total motility count after processing of at least 1000 000 spermatozoa per ml

Exclusion Criteria:

  • All ICSI cycles
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00710476

Sponsors and Collaborators
University Hospital, Gasthuisberg
Principal Investigator: Thomas D'Hooghe, Prof. Dr. University Hospital Leuven, Leuven, Belgium
  More Information

No publications provided

Responsible Party: Prof. Dr. T D'Hooghe, University Hospital, Gasthuisberg, Leuven, Belgium
ClinicalTrials.gov Identifier: NCT00710476     History of Changes
Other Study ID Numbers: dwille2
Study First Received: January 4, 2008
Last Updated: July 2, 2008
Health Authority: Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment

ClinicalTrials.gov processed this record on October 23, 2014